Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmaceutical Chemistry > Pharmaceutical Chemistry > Flashcards

Pharmaceutical Chemistry Flashcards

You may prefer our related Brainscape-certified flashcards:
AP® Chemistry flashcards Periodic Table flashcards Chemistry 101 flashcards Organic Chemistry 101 flashcards
1
Q

Ligands

A

Compounds that bind to a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Potency

A

The amount of drug that must be administered in order to produce a desired effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is ED50?

A

The dose which produces the effect in 50% of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Receptor

A

Any cellular macromolecule to which a drug binds and thereby initiates its characteristic biological effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Extraction

A

Separation of substance from a matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bio guided fractionation

A

Reduces wide range of chemicals present in an extract through removal of substances based in similar chemical properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ethnopharmacology

A

the traditional use of natural products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Biodiversity

A

degree of variation of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In vitro

A

conducted using components of an organism that have been isolated from their usual biological surroundings in order to permit a more detailed or more convenient analysis that can be done with whole organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In vivo

A

conducted with living organisms in their normal intact state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In silico

A

performed on a computer or via computer simulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

computational chemistry

A

target directed modeling of a compound to elevate the interaction between a receptor and the chemical structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

High Throughput Screening (HTS)

A

a method for scientific experimentation especially used in drug discovery. Allows a researched to quickly conduct millions of chemical, genetic, or pharmaceutical tests. You can rapidly identify active compounds, antibodies, or genes which modulate a particular biomolecular pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pharmacophore

A

necessary structure for binding to the target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Human studies are divided into what three stages?

A

Phase I clinical trials (healthy volunteers)
Phase II clinical trials (patients-small population)
Phase III clinical trials (patients-large population)
Phase IV trials (patients-for evaluation of rare side effects and monitoring of efficacy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

parenteral administration

A

delivers drugs directly into bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

enteral administration

A

oral route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

physicochemical properties include?

A

ionizable functional groups
solubility
lipophilicity
molecular weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

pharmacokinetics

A

process by which a drug enters the body, distributes through it, is altered through metabolism and is excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

LADME model

A 
Liberation
Absorption
Distribution
Metabolism
Excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Liberation

A

important for ideal absorption into the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

extended release

A

drug formulated to slowly dissolve over an extended period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Absorption

A

when an unionized substance is dissolved in an aqueous solution, it can either passively diffuse across a lipophilic membrane to cross into the body or be actively transported across the membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Passive diffusion

A

concentration gradient; high concentration to low concentration across a membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

active transport

A

involves a carrier protein located inside the membrane and utilizes energy to actively transport a substance across the membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

bioavailability

A

the fraction of the total drug amount given that will be available in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lipinski’s Rule of 5

A 
not more than 5 H bond donors
not more than 10 H bond acceptors
MW below 500 Dalton
Partition coeff. logP below 5
rough estimate of the likeliness of a drug to show a high bioavailability if given orally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Distribution

A

if the drug is very hydrophilic, it will not distribute into certain tissues and is less likely to cross the blood brain barrier without a specific transporter. the more lipophilic a drug is, the easier it will distribute throughout the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Metabolism

A

set of life-sustaining chemical transformations within the cells of living organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

cytochrome P450

A

metabolizes drugs to more soluble metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Excretions

A

when a drug gets secreted from the body. Water soluble=secreted through urine (kidneys); lipid-soluble= secreted through feces (gall bladder)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Van der Waals interactions

A

occurs between alkyl groups on the receptor and on the drug molecule caused by polarization of C-C bonds in close proximity of each other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Hydrogen bonding

A

interaction between polar molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Ionic interactions

A

occur between two charged species that carry an actual charge instead of just a polarization. Electrostatic attraction between opppositely charge ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Covalent bond

A

formed when one electron from each of two atoms contributed to form a bond between the two atoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Arrhenius acid

A

increases the concentration of [H+] ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Arrhenius base

A

increases the concentration of [OH-] ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Bronsted-Lowry acid

A

proton donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Bronsted-Lowry base

A

proton acceptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

ionization

A

mechanism by which an acid transfers a proton to a base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

dissolution

A

process of dissolving a solute in a solvent to form a homogeneous solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

pH=

A

-log[H+]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

pKa=-logKa

A

for strong acids: Ka>1

for strong bases: Ka

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

pKa+pKb=

A

pKw=14

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

electron withdrawing groups

A 
halides
aldehyde
ketone
carboxylic acid
esters
halide acids
cyanide
sulfate
quaternary amine
nitrite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

weak acid

A

pHpKa; lower [H+]; equilibrium shifts towards more ionized species (shift right)

pH=pKa; 50% of molecules ionized, 50% of molecules unionized

47
Q

weak base

A

pHpKa; [H+] ion decreases; molecules will mainly unionize

48
Q

% ionized=

A

100/1+10^pH-pKa

49
Q

Hydrophilicity

A

increases water solubility; optimizes drug formulations; important for dissolution after oral administration

50
Q

lipophilicity

A

increases lipid solubility; penetration through cell membranes; longer circulation in the body

51
Q

Pro-drugs

A

temporarily alters the physicochemical properties of a drug to provide it with more desirable properties for its administration

52
Q

logP

A

indicator of a substances lipid solubility in its unionized state

53
Q

logP=

A

sum[pi(organic fragments)]

54
Q

diffusion layer

A

consists of tightly bound molecules of water which are not easily disrupted by stirring

55
Q

Noyes-Whitney equation

A 
dw/dt=k (cs-ct)
dw=amount of drug going into solution
dt=time
k=time dependent constant
Cs= saturated solubility of the compound
Ct=concentration at any time t
56
Q

Hansch analysis

A

predicts how well a molecule will likely fit and interact with its intended target

57
Q

Quantal dose response

A

simple model to express the response of an enzyme, receptor, or animal to a drug is to correlate number of responses to the dose

58
Q

log-dose response curve

A

Provides a sigmoidal curve. The activity of a drug is displayed on the y-axis and the potency is displayed on the x-axis

59
Q

Activity

A

activation of the receptor or enzyme upon binding of the drug with subsequent physiological or pharmacological changes.

60
Q

Potency

A

How strong a drug binds to its target. A drug with high potency binds very strongly to the target and therefore requires less of the drug for the physiological or pharmacological change to occur.

61
Q

Agonist

A

An agonist binds to its target and activates it resulting in the physiological or pharmacological response

62
Q

Antagonist

A

binds to its target but does not activate it. Instead, antagonists prevent binding of agonists to the target.

63
Q

Partial agonists/antagonists

A

not all agonists lead to the activation of all targets that are occupied-in some cases only some of the occupied targets will be activated while other are only occupied

64
Q

Competitive antagonist

A

binds to the same site on the target as the agonist. The potency of the agonist decreases-a shift to the right on the log-dose response curve is observed

65
Q

Non-competitive antagonist

A

the antagonist binds to a different site than the agonist and prevents activation of the target. The agonist can still bind but the activity is reduced in the presence of a non-competitive antagonist while potency is not affected.

66
Q

Michaelis-Menten kinetics

A

The interaction between a drug [D] and a receptor [R] are the same as between a drug (S) and an enzyme (E)

67
Q

Lineweaver-Burke (double-reciprocal plot)

A

Allows for determination of the maximum velocity or activity Vmax/Emax of the reaction as well as Km/Kd

68
Q

Lineweaver-Burke equation

A

1/V=1/Vmax + 1/[S] x Km/Vmax for enzyme-substrate interaction
1/E=1/Emax + 1/[D] x Kd/Emax for medicinal chemistry

69
Q

Isoterism

A

The replacement of functional groups or parts of a molecule to alter the size and shape is often utilized to wither design structurally closely related drugs that maintain the pharmacological activity or to improve the binding and positioning affinity for the drug with the target

70
Q

Isoters

A

functional groups that function similar to one another

71
Q

1906 Pure Food and Drug Act

A

prohibited the interstate commerce of mislabeled food and drug products

72
Q

1911 Sherley amendement

A

required the label claims to be accurate-although the government had to proof intentional mislabeling

73
Q

1938 Federal Food, Drug, and Cosmetic Act

A

required that drug manufacturers evaluate the safety of a drug before it is being marketed and submit a new drug application for review to the FDA, had labeling requirements that had indicate adverse effects and potential hazards that has been observed before, and authorized the FDA to conduct unannounced inspections of dru manufacturing facilities

74
Q

1962 Kefauver-Harris Act

A

closed many of the loopholes in drug regulation

75
Q

Federal Controlled Substances Act

A

provided drug scheduling for drugs that could potentially lead to abuse and addiction

76
Q

Orphan Drug Act

A

intended to provide incentives to drug manufacturers to invest in drug development for rare diseases

77
Q

Extrinsic pathway

A

tissue damage leads to release of tissue factor

78
Q

Intrinsic pathways

A

tissue damage leads to release of kallikrein

79
Q

Plasminogen

A

can prevent or resolve a blood clot

80
Q

Pro-drugs

A

rapidly metabolized after absorption into the body to the active drug

81
Q

isoters

A

functional groups that function similar to one another

82
Q

bioisoters

A

share similar physical and chemical properties with one another and are used to optimize pharmacodynamics and pharmacokinetics

83
Q

Replacement of a carboxylic acid with a sulfonamide group does what?

A

preserves ionization but leads to inhibition of target due to change in topology

84
Q

Replacement of an ester with an amide does what?

A

reduces metabolism and increases half-life of the compound

85
Q

central compartment

A

the blood and highly perfused organs such as the liver lungs and kidneys(one compartment model) Ex. intravenous injection

86
Q

apparent volume of distribution (Vd)

A

reflects the volume that would be needed to achieve the same plasma concentrations of a substance in the body

87
Q

clearance (Cl)

A

links elimination of a drug from the body to its concentration over time

88
Q

area under the curve (AUC)

A

the total body exposure to the drug over the course of time from administration to elimination of the whole dose or after repeated dosing

89
Q

The most common phase 1 reactions of drugs:

A

oxidation and hydroylsis

90
Q

Phase II pathways

A 
Glucuronide conjugation
Sulfate conjugation
Glutathione 
Acetylation
Amino acid conjugation
Methylation
Fatty acid conjugation
Cholesterol esters
91
Q

minimum effective concentration (MEC)

A

minimum concentration of drug in plasma required to produce the therapeutic effect. It reflects the minimum concentration of drug at the receptor site to elicit the desired pharmacological response.

92
Q

minimum toxic concentration (MTC)

A

minimum concentration in which toxicity usually occurs

93
Q

Therapeutic window

A

blood concentration range between MEC and MTC

94
Q

biotransformation

A

the process of conversion of a drug into metabolites

95
Q

xenobiotic

A

low molecular weight organic molecules that are not used by the human body for nutritional or other physiological purposes

96
Q

Phase 1 reactions

A

introduce or uncover a hydrophilic functional group

97
Q

Phase 2 reactions

A

an endogenous, usually water soluble, small molecule combines with a functional group of the drug or drug-metabolite

98
Q

The most abundantly expressed CYP in human intestines and liver is?

A

CYP3A4

99
Q

transporters

A

proteins that facilitate the elimination of drugs and drug metabolites out of cells

100
Q

Factors affecting drug biotransformation and duration of drug action:

A

amount of enzyme
affinity
availability of co-factors and co-substrates
inhibition

101
Q

Bloodborne pathogen

A

any pathogenic (disease causing) microorganism present in human blood that causes disease

102
Q

developmental validation

A

includes characterization of the locus, species specificity studies, sensitivity, stability, and mixture studies.

103
Q

internal validation

A

must be conducted by any lab when delveloping validation has been performed by another lab or at another site of a multi-site lab

104
Q

Good Manufacturing Practice (GMP)

A

intended to provide a set of processes that are validated to result in consistent and repeatable quality of the product at every stag of the manufacturing process

105
Q

Good Laboratory Practice (GLP)

A

adequate testing of intermediates and final drug products to ensure continuous high quality and detect deviations from the predetermined standards ASAP.

106
Q

Good Clinical Practice (GCP)

A

involves all activities related to human subject research, especially in regards to ethical standards, adequate protocol development for research projects, safety, and oversight of clinical trials.

107
Q

What factors are considered before purchasing instruments for a lab?

A 
Technical and service support provided
Price
Lab environment
Number and size of samples
Installation
Operation
Number of units required
Special reqs
108
Q

Equipment qualification

A

process by which an instrument is checked for compliance with previously determined standards of function and performance

109
Q

Validation

A

establishing documented evidence which provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes

110
Q

Inspections

A

the examination or measurement of an item or activity to verify conformation to specific requirements

111
Q

Calibration

A

a comparison of a measurement standard, instrument, or item with a standard or instrument of higher accuracy to detect and quantify inaccuracies and to report or eliminate those inaccuracies by adjustments

112
Q

Chain of Custody (COC)

A

an unbroken trail of accountability that ensures the physical security of samples, data and records

113
Q

A chain of custody must include:

A

the signature or initials of each individual receiving or transferring evidence, the date for each transfer with a corresponding identifier which specifies each evidentiary item

114
Q

Required information on sample collections include:

A

date and time of sample collection
name of person collecting samples
unique identification number for each individual sample
documentation that sample collection equipment and containers are clean
secure storage of all samples under specified conditions while awaiting transport

Pharmaceutical Chemistry (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions